# Vitamin D and Carboxy PTH Fragments in Coronary Calcification

> **NCT00502268** · PHASE4 · WITHDRAWN · sponsor: **Southeast Renal Research Institute**

## Conditions studied

- Coronary Calcification
- Endstage Renal Disease
- Parathyroid Hormone

## Interventions

- **DRUG:** Doxercalciferol administration
- **DRUG:** Doxercalciferol administered by 1-84-7-84

## Key facts

- **NCT ID:** NCT00502268
- **Lead sponsor:** Southeast Renal Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study never initiated
- **Last updated:** 2020-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502268, "Vitamin D and Carboxy PTH Fragments in Coronary Calcification". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00502268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*